• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY UNKNOWN VENTRICLEAR CATHETER; CATHETER, VENTRICULAR (CONTAINING ANTIBIOTIC O

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY UNKNOWN VENTRICLEAR CATHETER; CATHETER, VENTRICULAR (CONTAINING ANTIBIOTIC O Back to Search Results
Model Number UNKNOWN
Device Problem Insufficient Information (3190)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2022
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Philipp spindler, ingo fiss, henrik giese, elvis hermann, johannes lemcke, martin u.Schuhmann, ulrich-wilhelm thomale, andreas schaumann.Angulation toward coronal convexity measure and catheter length indication improves the quality of ventricular catheter placement a smartphone-assisted guidance technique.World neurosurgery (2022).Doi: 10.1016/j.Wneu.2021.12.036.Background: accurate placement of a ventricular catheter (vc) is crucial to reduce the risk of shunt failure.In the randomized, prospective, multicenter gavca (guided application of ventricular catheters) trial, which evaluated the quality of vc placement, the subgroup of patients with detailed length-marked vcs (dvcs) reflected a difference in the primary endpoint of optimal vc placement compared with the subgroup of patients with simplified length marked vcs (svcs).The objective of the present analysis was to compare the dvc and svc groups and the smartphone-assisted guidance technique (ga) with the standard freehand technique (fh) for vc placement.Methods: we performed a further analysis of the gavca trial in 2 steps.First, we compared the dvcs, which provided a detailed distance from the tip to the base (3-13 cm) in 0.5-cm intervals, with the svcs with a length indication at 5 and 10 cm from the tip to base.Second, we compared the ga technique with the fh in the dvc group.Results: the data from 137 patients (104 dvc patients vs.33 svc patients) were eligible for the present analysis.Optimal vc placement was achieved in 72.1% of the dvc group and 39.4% of the svc group (odds ratio, 3.9; 95% confidence interval, 1.7e9.3; p 0.001).In addition, we performed a subgroup analysis of the 104 dvc patients concerning the accuracy of catheter placement using 2 different techniques (ga, n 54; and fh, n 50).Optimal catheter placement was achieved in 81.5% of the ga group and 62.0% of the fh group (odds ratio, 2.7; 95% confidence interval, 1.1e6.8; p 0.03).Vc placement using the ga technique was successful in all patients at the primary puncture.In contrast, for 8.7% of the patients in the fh group, multiple attempts were necessary (p 0.03).Conclusions: the results from the present analysis suggest that the combination of a ga technique and the use of a dvc will improve the rate of accurate vc placement.Compared with the fh technique, patient safety was increased by the reduction of unsuccessful vc placement attempts using the ga technique and dvcs.Reported events: an incorrect catheter position had occurred in 36.4% of the svc group.Incorrect catheter positioning was defined when the vc position was grade iii or iv, not ipsilateral, or when multiple punctures were necessary.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN VENTRICLEAR CATHETER
Type of Device
CATHETER, VENTRICULAR (CONTAINING ANTIBIOTIC O
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
5290 california ave
irvine CA 92617
Manufacturer Contact
glen belmer
9775 toledo way
irvine, CA 92618
6122713209
MDR Report Key13535720
MDR Text Key293096025
Report Number2021898-2022-00065
Device Sequence Number1
Product Code NHC
Combination Product (y/n)N
Reporter Country CodeGM
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 02/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberUNKNOWN
Device Catalogue NumberUNKNOWN
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/04/2022
Initial Date FDA Received02/15/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-